11 completed, 1 terminated. 12 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 11, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow ropinirole: new trials by email Literature Review of ropinirole trials Research Report on ropinirole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole Ropinirole oral product, Ropinirole Implant - Parkinson Disease | Phase 1 / Phase 2 | Terminated | Titan Pharmaceuticals | 6 | 2017-10-10 | 2023-05-06 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Ropinirole - Hyperprolactinemia, Prolactinoma | Phase 1 / Phase 2 | Completed | Columbia University | 16 | 2016-09-16 | 2024-06-04 |
| Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects Ropinirole - Parkinson Disease | Phase 1 | Completed | GlaxoSmithKline | 24 | 2010-06-28 | 2018-06-19 |
| Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition Ropinirole - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 48 | 2009-10-01 | 2012-09-28 |
| Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition Ropinirole - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 48 | 2009-10-01 | 2012-09-28 |
| Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets Test Product (Ropinirole), Reference Product (REQUIP ) - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-23 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions Ropinirole hydrochloride CR Tablets 2mg - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-30 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions Ropinirole hydrochloride CR 2mg Tablets - Pharmacokinetic Study | Phase 1 | Completed | Lupin Ltd. | 12 | 2008-09-01 | 2012-10-26 |
| Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food Ropinirole - Restless Legs Syndrome | Phase 1 | Completed | GlaxoSmithKline | 32 | 2006-08-24 | 2017-10-13 |
| Ropinirole Tablets In Young Patients With Restless Legs Syndrome Ropinirole Immediate Release - Restless Legs Syndrome | Phase 1 | Completed | GlaxoSmithKline | 9 | 2005-06-10 | 2017-09-11 |
| The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions Ropinirole HCl 0.25 mg Tablets, Requip® 0.25 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 46 | 2004-11-01 | 2009-09-15 |
| Ropinirole 0.25 mg Tablets Under Fasting Conditions Ropinirole HCl 0.25 mg Tablets, Requip® 0.25 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 44 | 2004-10-01 | 2009-09-11 |
Parkinson Disease (2) · Restless Legs Syndrome (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dyskinesias (1) · Hyperprolactinemia (1) · Movement Disorders (1) · Neurodegenerative Diseases (1) · Parkinsonian Disorders (1) · Prolactinoma (1)
GlaxoSmithKline (3) · Lupin Ltd. (3) · Dr. Reddy's Laboratories Limited (2) · Teva Pharmaceuticals USA (2) · Columbia University (1) · Titan Pharmaceuticals (1)
India (5) · United States (5) · Belgium (1) · China (1) · France (1) · Germany (1) · South Africa (1)
Satyanarayana V, M.Pharma., Ph.D (3) · Dr. Naba Kr Talukdar, MD (2) · Dr. Kate Beebe DeVarney (1) · Gabrielle Page-Wilson, M.D. (1) · So Ran Hong, M.D. (1) · Soran Hong, M.D. (1)
R21DK112093 (1)